| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 660,100 | 315,600 | 490,300 | 414,600 | | Cost of Revenue | 269,700 | 156,100 | 225,600 | 210,500 | | | Gross Profit | 390,400 | 159,500 | 264,700 | 204,100 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 229,800 | 173,700 | 190,500 | 172,300 | | Non Recurring | 42,300 | 4,300 | 6,700 | 36,800 | | Others | 12,700 | 16,800 | 20,000 | 16,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 105,600 | (35,300) | 47,500 | (21,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 900 | 1,600 | (13,200) | | Earnings Before Interest And Taxes | 97,400 | (34,400) | 49,100 | (34,200) | | Interest Expense | (3,900) | 3,900 | 5,700 | 5,600 | | Income Before Tax | 101,300 | (38,300) | 43,400 | (39,800) | | Income Tax Expense | 44,500 | (13,700) | 10,800 | (5,700) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 56,800 | (24,600) | 32,600 | (34,100) | | | Non-recurring Events | | Discontinued Operations | (1,300) | 1,600 | (4,900) | (1,900) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 55,500 | (23,000) | 27,700 | (36,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $55,500 | ($23,000) | $27,700 | ($36,000) |
|
0.31% Nasdaq 0.00%
Income Statement
